García-Montalvo B

Language: Spanish
References: 25
Page: 367-372
PDF size: 48.42 Kb.

ABSTRACT

Background: blood transfusion is the second most frequent way of Trypanosoma cruzi (T. cruzi) transmission in Latin American countries. Few data exists on the geographic distribution and prevalence of T. cruzi seropositive blood donors in Mexico. The objective was to document T. cruzi antibody distribution, and identify the regions with the highest prevalence of seropositive blood donors.
Methods: the analyzed data was collected over a six-year period during blood donations made at the Central Blood Bank and at the transfusion services and donation modules of the Instituto Mexicano del Seguro Social ( IMSS) located in the Yucatan state.
Results: Trypanosoma cruzi antibody reactivity was determined in 86343 blood donors. Overall seroprevalence was 0.70 % (607/ 86 343). Since 2002 to 2004, the majority (58 %) of seropositive donors were rural residents, but since 2005 to 2007 the majority (56.6 %) were urban residents. The two highest seroprevalences by region were in the Metropolitan area (0.42 %) and in rural south Yucatan (0.09 %). Most seropositive donors resided in the municipality of Merida (60.3 %).
Conclusions: seroprevalence distribution was heterogeneous during the study period but urban transmission has apparently surpassed rural transmission in recent years.

REFERENCES

1. World Health Organization. Control of Chagas disease. WHO Technical Report Series no. 905. Geneva: WHO; 2002.

2. Gales SA, Kirchhoff LV. Risk factors for Trypanosoma cruzi infection in California blood donors. Transfusion 1996;36 (3):227-231.

3. Schmunis GA, Zicker F, Pinheiro F, Brandling-Bennett D. Risk for transfusion-transmitted infectious diseases in Central and South America. Emerg Infect Dis 1998;4(1):5- 11.

4. Schmunis GA. Trypanosoma cruzi, the etiologic agent of Chagas disease: status in the blood supply in endemic and non endemic countries. Transfusion 1991;31(6):547-555.

5. Carvalho MF, de Franco MF, Soares VA. Amastigotes forms of Trypanosoma cruzi detected in a renal allograft. Rev Inst Med Trop de Sao Paulo 1997;39(4):223-226.

6. Center for Disease Control and Prevention. Chagas disease after organ transplantation—Los Angeles, California, 2006. MMWR Morb Mortal Wkly Rep 2006;55(29): 798- 800.

7. Guzmán-Bracho C, Lahuerta S, Velasco-Castrejón O. Chagas disease. First congenital case report. Arch Med Res 1998;29(2):195-196.

8. Sánchez-Negrete O, Mora MC, Basombrío MA. High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina. Pediatrics 2005;11 5(6):e668-672.

9. Sánchez-Guillén MC, Barnabé C, Guégan JF, Tibayrenc M, Velásquez-Rojas M, Martínez-Munguía J, et al. High prevalence anti-Trypanosoma cruzi antibodies, among blood donors in the state of Puebla, a non-endemic area of Mexico. Mem Inst Oswaldo Cruz 2002;97(7):947-952.

10. Leiby DA, Lenes BA, Tibbals MA, Tames-Olmedo MT. Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. N Engl J Med 1999; 341(16):1237-1239.

11. Cruz JR, Pérez-Rosales MD. Availability, safety, and quality of blood for transfusion in the Americas. Rev Panam Salud Publica 2003;13(2-3):103-110.

12. Owusu-Ofori S, Temple J, Sarkodie F, Anokwa M, Candotti D, Allain JP. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion 2005;45(2):133-140.

13. Schmunis GA, Cruz JR. Safety of the blood supply in Latin America. Clin Microbiol Rev 2005;18(1):12-29.

14. Ramos-Ligonio A, Ramírez-Sánchez ME, González- Hernández JC, Rosales-Encina JL, López-Monteon A. Prevalence of antobodies against Trypanosoma cruzi in blood bank donors from the IMSS General Hospital in Orizaba, Veracruz, Mexico. Salud Publica Mex 2006;48(1):13-21.

15. Rangel H, Gatica R, Ramos C. Detection of antibodies against Trypanosoma cruzi in donors from a blood bank in Cuernavaca, Morelos, Mexico. Arch Med Res 1998; 29(1):79-82.

16. Hernández-Becerril N, Mejía AM, Ballinas-Verdugo MA, Garza-Murillo V, Manilla-Toquero E, López R, et al. Blood transfusion and iatrogenic risks Mexico city. Anti-Trypanosoma cruzi seroprevalence in 43 048 blood donors, evaluation of parasitemia, and electrocardiogram findings in seropositive. Mem Inst Oswaldo Cruz 2005;100(2):111-116.

17. Dumonteil E, Gourbiere S. Predicting Triatoma dimidiata abundance and infection rate: a risk map for natural transmission of Chagas in the Yucatan peninsula of Mexico. Am J Trop Med Hyg 2004;70(5):514-519.

18. Dumonteil E. Update on Chagas´ disease in Mexico. Salud Publica Mex 1999;41(4):322-327.

19. Trujillo-Contreras F, Lozano-Kasten F, Soto-Gutiérrez MM, Hernández-Gutiérrez R. The prevalence of Trypanosoma cruzi infection in blood donors in the state of Jalisco, Mexico. Rev Soc Bras Med Trop 1993;26(2):89-92.

20. Ramos-Echevarría AA, Monteón-Padilla VM, Reyes- López PA. Seroprevalence of antibodies to Trypanosoma cruzi in blood donors. Salud Publica Mex 1993;35(1):56- 64.

21. Monteón-Padilla VM, Hernández-Becerril N, Guzmán- Bracho C, Rosales-Encina JL, Reyes-López PA. American trypanosomiasis (Chagas´ disease) and blood banking in Mexico city: seroprevalence and its potential transfusional transmission risk. Arch Med Res 1999;30(5):393-398.

22. Cohen J, Gürtler RE. Modeling household transmission of American trypanosomiasis. Science 2001;293(5530):694-698.

23. Gürtler RE, Cécere MC, Rubel DN, Petersen RM, Schweigmann NJ, Lauricella MA, et al. Chagas disease in Northwest Argentina: infected dogs as a risk factor for the domestic transmission of Trypanosoma cruzi. Trans R Soc Trop Med Hyg 1991;85(6):741-745.

24. Jiménez-Coello M, Poot-Cob M, Ortega-Pacheco A, Guzmán-Marín E, Ramos-Ligonio A, Sauri-Arceo CH, et al. American trypanosomiasis in dogs from an urban and rural area of Yucatan, Mexico. Vector Borne Zoonotic Dis 2008;8(6):755-761.

25. Guzmán-Tapia Y, Ramírez-Sierra MJ, Dumonteil E. Urban infestation by Triatoma dimidiata in the city of Merida, Yucatan, Mexico. Vector Borne Zoonotic Dis 2007;7(4):597-606.